hong-kong-skyline.png
Limited Partners

Former Carlyle Asia and Warburg Pincus execs launch pan-Asian secondaries fund

Noveon Capital has completed three deals and targets Greater China

Noveon Capital, a Hong Kong-based secondaries firm founded by former Carlyle and Warburg Pincus executives, is targeting $150 million for a debut fund focused on China.

It has already done three deals in stealth, buying ageing fund stakes at what it says are 40-50% discounts to mark.

One of them included an LP trade of GSR Ventures’ Fund IV. Noveon co-founder and managing partner Sung Ko said 92% of the fund is invested in Xiaohongshu, the Chinese social media platform also known as RedNote.

Some 95% of LP-led volume in 1H2026 was in North America- and Europe-focused funds, according to Jefferies’ Global Secondary Market Review.

Meanwhile, Asia is sitting on an overhang of ageing funds and assets that has built up since the 2021 global market correction. Many of these Asian and emerging-market assets trade at discounts of more than 35% to net asset value, against an average of 13% across LP portfolios, Jefferies said.

SUNGKO

Sung Ko, founding managing partner, Noveon Capital

Image courtesy of Noveon Capital

Ko spent 11 years at Carlyle, most recently as a managing director in Carlyle Asia. His co-founder, Chris Shen, spent 12 years at Warburg Pincus and Bain Capital.

Noveon Capital writes $5 million-$50 million cheques and targets ageing funds with more than 50% of their exposure in a single asset. These “trophy assets” can often come at compelling discounts as Asian funds struggle to raise new funds in the primary market.

The firm is pursuing a two-pronged fundraising strategy: raising both a closed-ended vehicle and multiple deal-by-deal special-purpose vehicles, with the latter focused on Asia’s growing circle of private wealth, family offices and high-net-worth investors.

This interview has been edited for brevity and clarity.

Sign up for Capital Pool

Weekly commentary on what’s driving LP decision-making, with senior funds columnist Jessica Hamlin.

PitchBook: Where do you see most of these deals coming from in APAC?

Ko: We think the biggest opportunity set is in China. China represents over 65 per cent of Asia private equity AUM. The last real big-dollar funds, raised in US dollars in the past five years, were Chinese GPs’, and many of their investment periods have ended.”

There is an incentive for them to go through the route of providing liquidity exits and create continuation vehicles so that they have continued exposure.

My partner, Chris [Shen], has gone directly to these USD China GPs, helped them understand how the CV works, how they can position this in front of their clients and LPs and which assets we think would be the most appropriate.

On my side, I’m going to the US endowments, foundations, high-net-worth individuals, family offices and funds of funds that have held these positions for more than 10 years. In our first three positions, the average fund life was 15 years. They are typically concentrated in one strong key asset, which we can buy at a 40-50 per cent discount to its mark.

Are US LPs still selling their China assets?

Historically, most investors in China were US investors. If you look back 10 years, endowments, foundations and family offices in the US were among the largest investors in China.

Two things have happened.

Number one, most of the funds they invested in are now on average 10 years old. They’re effectively expired. The challenge is that they put it into an auction process, but most of the secondary buyers don’t want the Asia or China positions. So they become very unattractive to acquire. We think that creates the opportunity for us to be an acquirer of those types of opportunities.

Latest Research

Greater China Private Capital Breakdown

The 2026 Greater China Private Capital Breakdown spans datasets covering Greater China’s VC and PE deals by sector and region, as well as exit and fundraising activity.

Number two is, if it’s just a straight discount and even if it’s a discount of 30%, people still don’t want to acquire it because getting to 1x distributions to paid-in has taken so much longer than in North America.

The tail end of funds in North America is over 5-7 years old. But in Asia, that tail end of funds is 11-15 years old, which means it takes 11 years to reach 1x DPI. So even a 30% discount isn’t as good as it sounds. If you’re stuck holding for another 3-4 years, the discount spread over that time may not be as attractive on a per-year basis.

When you think about US LPs who are trying to sell, you typically run it through an auction process, which is very limited. But if you go directly to them, they’re much more open. So I think the opportunity set is about not waiting for it to come to you. You have to go after it and reach out.

We also see US LPs exiting for geopolitical reasons, as the Asian and Middle East LPs are coming in. Middle Eastern LPs use this as a way to gain exposure to Asia instead of going directly into funds.

How do Chinese assets stack up against other APAC markets like India in terms of growth metrics, deal quality and valuation?

We’re looking at businesses that are growing in the high teens to low 20s on the top line and in the double digits on the bottom line. With the secondary discount, we’re buying these companies which are at scale at 7-10x.

ByteDance is a good example. It’s growing just as fast and at scale as Facebook, but you can buy at 8x while Facebook’s probably trading around 16x. We think that these types of trophy assets remain in Asia and particularly in China. This isn’t just about identifying the right asset, but about understanding the right motivations and intentions for the GP.

Particularly in China, the best assets are ones they want to hold on. You see that in Centurium Capital with Luckin Coffee, CITIC Capital with McDonald’s China, Hongshan Capital with ByteDance. For many of these funds, once you have a trophy asset, you want to keep it because once you sell and return it, it’s difficult to find another one.

The opportunity is relatively smaller in the broader Asia context and that’s where I think the challenge is. Even in India, deal volumes have been relatively less until more recently. This will likely increase in the next 5 years especially if IPOs in India become much more challenged, but this will come in waves.

Why would a GP want to let go of their prized assets if these trophy assets are so difficult to come by?

For GPs, they realise that doing a CV is really beneficial to them because if I have an old fund that is unlikely to hit carry, but that deal is outperforming, and the fund is under the hurdle, they won’t receive carry.

So if I am able to restructure it, sell it out of that old fund and put it into a new vehicle where I can charge real economics, call it 1% management fee on NAV instead of at cost, plus 10% carry, versus the old vehicle, where I wouldn’t hit carry because the fund level is under the hurdle, it makes it really attractive for them because of those considerations.

$60 billion was raised in Asia just this past year. Most of that was raised across three large GPs—Bain Capital, EQT and Blackstone. The other 1,300 managers raised only 15% of that capital. But more importantly, the last time China US dollar funds raised anything was back in 2019-20 before COVID. Now they’re all coming back to market to raise capital.

So the question now becomes, do I need to get the money back? My investment period for my old fund has ended, so I step down on management fees. That’s where the biggest change is because if I knew I was still going to be in business and raise another fund, that’s one thing. But that’s three managers in all of Asia PE today, right? Everyone else is trying not to have a melting ice cube. Nobody wants to be a zombie GP.

Tell me more about your fundraising strategy?

Most of our investors are PE executives across Asia who have come into our deals and invested alongside us. That’s how we thought about building our roster base, instead of going to the big institutional investors and trying to convince them.

Our goal is to raise $150 million for our first-time fund. But in addition to that, we are doing deal-by-deal SPVs, which we believe will help us scale. I think this is one of the biggest changes happening in Asia.

Everyone talks about how much closed-end funds have raised. Last year it was about $60-70 billion. But we estimate there’s probably another $50 billion in single-deal SPVs that have been raised, much of which was for US opportunities like SpaceX and Anthropic.

There’s an entire universe of Asian high-net-worth and family office money which is looking at more single-deal SPVs than looking at funds.

So we think that being an institutionalised manager today isn’t just about going after and raising capital for closed-end funds, but about doing it for each deal and CV, which becomes a way to access this source of capital.

Most of the evergreen funds outside of North America are raised in Asia, specifically in two cities, Hong Kong and Singapore. The private banks like UBS and DBS are all raising evergreen secondary funds.

So you’ll be raising a closed-ended fund and doing deal-by-deal SPVs concurrently?

Yes, we’re going to do both. I think this is the biggest change, where each of the deals is going to be typically the size that our closed-end fund gets exposure to, all of these opportunities. Each of these CVs might be $100 million. If our closed-end fund was $150 million, that would be too big, right?

So what has changed is that each deal will have an SPV that we raise capital for, in addition to its investment into the closed-end fund. That’s the big innovation.

What is happening that hasn’t really been discussed is that there are a lot of Asian GPs who have tried to innovate out of necessity in their business. They raise single-asset SPVs for things they can get access to, like ByteDance.

These GPs then sell it to their LPs on a deal-by-deal basis. That was very common for Anthropic and OpenAI. Many of the GPs in the US tapped out of their funds to raise money from their LP roster for these opportunities. We believe that model of being quote-unquote open architecture is the future in Asia.

Recent News

Weil Gotshal quietly incubated an AI-native Big Law challenger before its collapse

The new company, Kepler, is looking to raise hundreds of millions of dollars and will target high-margin M&A work with an eye to launching in Q1 2027.

Why Wall Street wants to trade AI compute like oil

A new boom in tech industrialization changes the face of Silicon Valley’s capital stack.

Learn about our editorial standards.